PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20974202-3	2010	To test this possibility, we first performed a previous insult with quinolinic acid (QA) to specifically damage the striatal GABAergic neuronal cell bodies in order to remove the nigral BDNF target.	Quinolinic Acid	68-83	brain derived neurotrophic factor	Homo sapiens	186-190	
20974202-3	2010	To test this possibility, we first performed a previous insult with quinolinic acid (QA) to specifically damage the striatal GABAergic neuronal cell bodies in order to remove the nigral BDNF target.	Quinolinic Acid	85-87	brain derived neurotrophic factor	Homo sapiens	186-190	
32408403-4	2020	In this study, we transplanted BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) into the contra-lateral side of unilateral quinolinic acid (QA)-lesioned striatum of HD rat model.	Quinolinic Acid	132-147	brain derived neurotrophic factor	Homo sapiens	31-35	
18323792-0	2008	AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment.	Quinolinic Acid	33-48	brain derived neurotrophic factor	Homo sapiens	4-8	
18323792-2	2008	In this study we demonstrate that overexpression of BDNF in the striatum attenuates motor impairment and reduces the extent of striatal damage following quinolinic acid lesioning.	Quinolinic Acid	153-168	brain derived neurotrophic factor	Homo sapiens	52-56	
11150327-5	2001	Intrastriatal injection of quinolinate, kainate, 3-nitropropionic acid, or colchicine increased BDNF mRNA levels in cerebral cortex.	Quinolinic Acid	27-38	brain derived neurotrophic factor	Homo sapiens	96-100	
10964490-0	2000	Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections.	Quinolinic Acid	56-71	brain derived neurotrophic factor	Homo sapiens	28-32	
10964490-2	2000	Here we have measured changes in the developmental expression pattern of BDNF and NT-3 in the striatum, cortex, and substantia nigra induced by intrastriatal injection of the N-methyl-d-aspartate glutamate receptor agonist quinolinic acid (QUIN).	Quinolinic Acid	223-238	brain derived neurotrophic factor	Homo sapiens	73-77	
10964490-2	2000	Here we have measured changes in the developmental expression pattern of BDNF and NT-3 in the striatum, cortex, and substantia nigra induced by intrastriatal injection of the N-methyl-d-aspartate glutamate receptor agonist quinolinic acid (QUIN).	Quinolinic Acid	240-244	brain derived neurotrophic factor	Homo sapiens	73-77	
10825501-4	2000	In particular, BDNF prevents cell death of certain striatal populations in excitotoxic models of Huntington disease (HD) following intrastriatal injection of quinolinic acid to the adult rodent brain.	Quinolinic Acid	158-173	brain derived neurotrophic factor	Homo sapiens	15-19	
33261317-9	2020	QUIN exposure down-regulated CREB, BDNF, and synaptic protein expression in neurons.	Quinolinic Acid	0-4	brain derived neurotrophic factor	Homo sapiens	35-39	
32408403-4	2020	In this study, we transplanted BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) into the contra-lateral side of unilateral quinolinic acid (QA)-lesioned striatum of HD rat model.	Quinolinic Acid	149-151	brain derived neurotrophic factor	Homo sapiens	31-35